Background: Preoperative saline deflation is a clinically useful intervention in revisional breast surgery. It allows suspensory ligament recovery, reveals true glandular volume, and simplifies mastopexy markings. Presently unknown are the volumetric changes that occur after deflation. Objectives: The authors report the three-dimensional (3D) changes that occur with preoperative deflation prior to revisional breast surgery. Methods: We reviewed available charts of revisional breast surgery patients who underwent preliminary saline implant deflation. Our protocol is deflation 4 weeks prior to revision. Three weeks following deflation, the patient is evaluated to finalize the operative plan, including the need for implants, mastopexy, and adjunctive procedures. A subset underwent 3D imaging to quantify the volumetric changes over the 3-week deflation period. Results: Between 2002 and 2014, 55 patients underwent saline implant deflation prior to 57 revisional surgeries. Seventeen were revised without implants and 40 with implants. The 3D subset of 10 patients showed a mean 15.2% volume increase and 0.18 cm notch-to-nipple distance decrease over the 3 weeks following deflation and prior to definitive surgical correction. Conclusions: Breast volume increases and the notch-to-nipple distance decreases during the 3-week interval prior to reoperation. This "elastic breast recoil" occurs after the mass effect of the implant is removed, resulting in recovery of stretched suspensory ligaments and gland reexpansion. We believe 4 weeks is optimal for gland normalization. Ideal candidates include patients requiring secondary mastopexy without implants, implant downsizing in the same pocket, and secondary augmentation mastopexy. Preoperative saline deflation and 3D analyses are useful for preoperative planning in reoperative breast surgery.
for additional revisions. Deflation is particularly useful when a smaller implant is needed. After a period of deflation, the capsule contracts and becomes smaller, permitting a more exact fit of the smaller implant into the pocket without the need for extensive capsulorrhaphy.
We began preoperative saline deflation in 2002, and observed that after a period of deflation, the breast envelope appeared to tighten and the parenchyma re-expanded. 1 We hypothesized that this "elastic breast recoil" occurred after the mass effect of the implant was removed, allowing recovery of stretched suspensory ligaments and gland re-expansion back toward its pre-augmented volume (Figure 1 ). After the trial deflation period, we arbitrarily developed a protocol to bring the patient back to the office 3 weeks following deflation to finalize the operative plan, including the need for implants, mastopexy, and adjunctive procedures. We tried to limit the total period of deflation to 4 weeks in order to minimize inconvenience to the patient. As we gained experience, we found deflation to be a clinically useful tool, and applied it to more patients. What we did not know was the ideal time period prior to secondary surgery to perform deflation and the precise volumetric and shape changes that occurred in the interim. We therefore studied all of our revisional breast patients who have undergone preoperative saline deflation to determine their outcomes. To further quantify the clinical phenomenon of elastic breast recoil, we then examined a subset of patients with 3D imaging to quantify the volumetric and shape changes.
METHODS
A retrospective 12-year chart review, from January 2002 to March 2014, of the senior author's revisional aesthetic breast surgeries, was performed to identify patients who had preoperative saline implant deflation. All patients who underwent preoperative saline implant deflation and had normal preoperative mammography reports were included. Patients were excluded if they had undergone preoperative silicone implant explantation, had incomplete records, or did not obtain preoperative mammography reports. We did not routinely require patients to provide postoperative mammography reports unless they had further revisional breast surgery at least 1 year after their index procedure. When this was required, we collected the reports, but did not require patients to provide mammography images. All patient identifiers were removed and data stored on-site with a password-protected drive. Since this was a retrospective chart review of a single surgeon's experience intended for clinical teaching purposes, this study was exempt from Institutional Review Board approval. Our standard procedure is to deflate saline implants 4 weeks prior to definitive revisional breast surgery (Supplementary Video 1). The volume of saline removed is recorded and compared to the operative note or, if not available, the patient's history. This volume aids determination of the final implant size. At 1 week prior to surgery, the patient is evaluated to determine the final operative plan, including the need for implants, mastopexy, and adjunctive procedures such as fat grafting. At that time, the patient is asked, "In a shaping bra, are you satisfied with the volume of your breast?" If she is satisfied with the volume, then she is offered either: (1) removal of the deflated saline implant alone; or (2) removal of the deflated saline implant and mastopexy with or without fat grafting. If she wants to be larger than her native breast volume, then she is offered: (1) removal and replacement with implant (often smaller than the implant that was explanted) and mastopexy with or without fat grafting; or (2) removal and replacement with or without fat grafting. In cases where the patient needs an implant for upper pole fullness, but has excessive lower pole breast tissue, we offer a removal and replacement with implant, and a small reduction (addition/ subtraction mastopexy). After determining the patient's goals, implants are ordered if needed (Figure 2 ).
Three-Dimensional Volume Measurement
A subset of patients had preoperative three-dimensional imaging (Vectra, Canfield, Fairfield, NJ) at three time points: at the initial consult (Time 1), immediately after deflation (Time 2), and 3 weeks after deflation (Time 3). Time 3 is 1 week before revisional surgery. Analyses of Figure 1 . Elastic breast recoil. (A) The interstitial pressure of the saline implant exerts outward force (black arrows) onto the breast parenchyma (green arrows) which also exerts pressure onto the implant and skin envelope. (B) After saline deflation, the interstitial pressure exerted by the saline implant onto the parenchyma (black arrows) drops, and the parenchyma is able to re-expand back towards its pre-augmented volume (green arrows). breast volumes and breast landmarks at these time points was performed and the time interval between Time 2 and Time 3 was recorded.
Removal and Implant Replacement
Using prior incisions, the submuscular capsule around the deflated saline implant is entered and the device is removed. Capsulectomy is performed only if the capsule is thick or calcified. Capsulorraphy is performed as needed to close down the submuscular capsule if a smaller implant is replaced into the submuscular space. If a pocket change to a subglandular pocket is chosen, then careful pocket dissection is carried out to accommodate the smaller implant. If a mastopexy is needed, the nipple areolar complex (NAC) is tailor tacked to the previously-marked position and adjusted as needed with the patient upright. A skin-only mastopexy is then performed if the upper pole volume is sufficient. If the upper pole is deficient, a superiorly-based parenchymal flap or fat grafting can be used to enhance the upper pole volume. We advocate a vertical approach for mastopexy as previously described. [2] [3] [4] This flap is used only when there is greater than 50 grams of tissue in between the medial and lateral pillars, as we have found that volumes less than 50 grams do not make a significant difference in enhancing upper pole volume. The pocket type is chosen based on the breast volume to implant ratio. If the patient has chosen smaller than a 250 mL device, and has pinch thickness >2 cm, then typically a textured round silicone implant is placed in the subglandular pocket. If a superiorly based parenchymal flap is needed, it is tucked underneath the gland, and on top of the implant. If the patient has chosen an implant larger than 250 mL, placement in the subglandular plane risks implant edge palpability, and it is our preference to place the implant in the submuscular plane. In this case a smooth round device is chosen. In general, our preferred implant volumes are smaller with augmentation mastopexy than with augmentation alone.
Removal With No Implant Replacement
If no implant is needed, then mastopexy and fat grafting are performed as described above after closing down the capsule with 2-0 Vicryl (Ethicon, Somerville, NJ).
RESULTS
All patients were female, and the average age was 43.7 years (range, 17-68 years). Out of 55 patients, eight had capsular contracture, and of those, four had Baker IV capsular contracture ( Figure 3 ). Fifty-five patients underwent 57 revisional breast surgeries following saline implant deflation. Seventeen procedures were performed without the use of implants: one with removal only, nine with concurrent mastopexy, two with fat grafting, two with mastopexy and fat grafting, and three with additional reduction, mastopexy, and fat grafting. Forty procedures required an additional implant: thirteen had replacement with an implant only (three whose previous implant volume was unknown, eight with smaller implants, two with larger implants); nineteen had removal, replacement, and mastopexy (one whose previous implant volume was unknown, seventeen with smaller implants, and one with larger implants); three had removal, replacement, mastopexy, and fat grafting (two with smaller implants, and one with larger implants); four had addition, subtraction, and mastopexy; and one had addition, subtraction, mastopexy, and fat grafting (Table 1) . After an average follow-up of 447 days (range, 1.2 years), there were no deflation-related complications. Specifically, there were no infections from deflated saline in the capsule, no psychological sequelae from the period of deflation, and no failures to proceed with revisional surgery. We require a commitment of payment in full at the time of deflation. There were three complications overall after revisional surgery: one patient had unilateral deflation of a saline implant requiring replacement, another had a minor wound dehiscence that resolved with wound care, and the last patient required a left periareolar mastopexy performed under local anesthesia.
Three-Dimensional Imaging Subset
A subset of 10 patients underwent 3D imaging at three time points: at the initial consult (Time 1), immediately after deflation (Time 2), and 3 weeks after deflation (Time 3). Using the Sculptor (Vectra, Canfield, Fairfield, NJ) program, breast landmarks were placed by hand, rather than by the computer automated landmarks, on the following landmarks: sternal notch, clavicles, nipples, apex of the areola, lateral inframammary fold (IMF), medial IMF, and IMF at the breast meridian. In order to eliminate the intra-observer variability of placing the breast landmarks, these landmarks were placed at three separate times, and the average of these values were recorded. To calculate volumes, the Analysis program (Vectra, Canfield, Fairfield, NJ) was used because, unlike the Sculptor measurement of volume, the Analysis program takes into account chest and abdominal wall irregularities.
Comparison of Volumes Between Time 2 and Time 1
The calculated volume difference between the initial consult (Time 1) and immediately post-deflation (Time 2) was recorded for each breast as "Δ volume T2 -T1." These volume differences were then compared to the actual deflation volume and the patient-reported volume of their saline implants (Table 2) . Of note, in our earlier patients, the volume removed was not consistently documented in the chart, and is referenced as "N/R" or "not recorded." In patient 2, the volume for the right and left breast by Vectra was calculated as 70.9 and 446.7 mL; the actual volume removed was 50 and 450 mL. For patient 5, the Vectracalculated volume difference was 388 mL and 355.1 mL; the actual volume removed was 400 and 325 mL.
Comparison of Volumes Between Time 3 and Time 2
These patients showed an average 15.45% (16.9% on the right and 14.0% on the left) increase in volume, as well as a decrease in the sternal notch-to-nipple distance of 0.18 cm (0.06 cm on the right and 0.3 cm on the left), over an average of 31.5 days of deflation ( Figures 3 and 4 , Supplementary  Figures 1 and 2 , Table 2 , Supplementary Videos 2 and 3).
DISCUSSION
We first began preoperative saline deflation in 2002-publishing select cases starting in 2007 [1] [2] [3] [4] [5] [6] -as a method to determine whether an additional implant or mastopexy only is necessary in revisional breast surgery. In the context of removing silicone implants during the moratorium, Rohrich et al 7 observed a rebound increase in breast volume over the initial 3 months, "most likely secondary to the natural restoration of the previously compressed breast tissue with a subsequent gain in superior fullness." Four options were available to the patient: (1) saline implant exchange; (2) explantation alone; (3) breast contouring with saline implantation; and (4) breast contouring alone.
Many women with saline implants may eventually seek revisional breast surgery. A common challenge in secondary aesthetic breast surgery is determining the true volume of the breast parenchyma versus that of the implant. Accurate assessment of parenchymal volume is important in determining whether the patient needs additional volume (another implant) or less volume (reduction) in conjunction with a mastopexy. A distinct advantage of saline implants is they can be deflated preoperatively to determine the true parenchymal volume. This was described by Fischman 8 in 2003. He deflated the implants right before surgery to facilitate preoperative marking. In Zaworski's 9 reply, he noted a 5-7 cm upward migration of the NAC after removal or deflation of subglandular saline implants. His algorithm was to remove the deflated saline implants 2-3 months prior to definitive mastopexy to allow the skin to contract. We started our saline deflation in 2002, but were unaware that others would publish their experience in 2003. Handel 10 described postoperative saline deflation after secondary augmentation mastopexy in order to decrease tension and improve circulation to skin flaps to avoid a complication. However, the duration of deflation, or the quantitative volumetric and shape changes that occur in the interim, have never been previously described.
After reviewing our 3D imaging data, we were able to quantify the clinical phenomenon of elastic breast recoil. Breast volume appears to increase on average 15.2% after saline implant deflation in the 3 week interval prior to reoperation. While this increase occurs in both the upper and lower pole, in some patients it is most noticeable from the basal view ( Figure 5 and Supplementary Videos 2 and 3) . A possible explanation for this is shortening of the suspensory ligaments that have previously been stretched by the implant, with resultant expansion of the gland back towards its preaugmented volume. Another explanation could be that after the implant is deflated, the pressure from the implant onto the parenchyma decreases. This drop in the parenchymal interstitial pressure allows fluid to reenter the interstitial tissue, much like a sponge absorbing water, to fill in the dead space left after implant deflation. Del Vecchio 11 describes this phenomenon as a drop in "subcutaneous tissue pressure" after implant removal that makes the SIEF method (Simultaneous Implant Exchange with Fat) possible.
This phenomenon of "elastic breast recoil" is important to note prior to secondary breast surgery. For example, if the revisional plan included removal of the existing saline implants, replacement with a smaller silicone implant, and a vertical mastopexy, there are several considerations. Using a smaller silicone implant will not elongate the sternal notch-to-nipple distance as much as a larger implant. The addition of a vertical mastopexy will further shorten the notch-to-nipple distance. The safe way to approach this would be to make conservative vertical mastopexy markings in the preoperative area and then, after the smaller implants are in place, perform a simulated stapled mastopexy and adjust the nipple height intraoperatively. However, despite this careful tailoring, the nipples may still end up too high. We hypothesize that this is due to the "elastic breast recoil," and that the notch-to-nipple distance will decrease when the larger implant is removed in the process of gland normalization. Just as in breast reduction, when weight is removed from the breast, the nipples elevate. In breast augmentation, weight is added, and the nipples lower. When a larger implant is replaced with a smaller one, the breast is unweighted, and the nipples elevate. This concept of unweighting the breast has previously been described. 12 Because these breast changes encompass the whole gland, we thought it would be best to track these changes with 3D imaging rather than anthropomorphic measurements alone.
We always offer deflation for patients with saline implants before the size change to smaller implants. It allows the patient to participate in the decision making of how large they want to be. If they want to downsize, it can be difficult for the patient to visualize and describe how much smaller they would like to be, and deflating the saline implant allows the patient to see how much of their own breast tissue they have to start with. For patients with silicone implants, we offer a staged approach of explantation then revisional surgery in two instances. First, if there is uncertainty as to the need for mastopexy, we find that a staged approach helps clarify the need for mastopexy. Second, we believe that when there is extracapsular silicone rupture, a staged approach after complete capsulectomy and removal of extravasated silicone allows the unstable soft tissue envelope to normalize. A period of waiting allows the blood supply to the breast to recover, which puts the patient at a lower risk for ischemic complications. The silicone implants are removed in the first operation (which is analogous to in-office saline implant deflation), and 3 weeks afterwards On average, the breast volume increases 15.2% (16.9% on the right, and 14.0% on the left); and the notch-to-nipple distance decreases 0.18 cm (0.06 cm on the right and 0.3 cm on the left) in the 3-week interval. N/R, not reported. a This patient had fully deflated spontaneously, so no more deliberate deflation was performed in the office.
we bring them back for final preoperative planning. The revisional surgery is performed 1 week later. Therefore, our staged approach is the same for both silicone and saline implants. We find this elastic breast recoil occurs in patients who have had both silicone explantation and saline deflation, and waiting until this recoil has occurred clarifies preoperative revisional planning. One weakness of this study is the small sample size. The percentage of new revisional breast patients requiring preoperative saline deflation is small, and all of these patients seen in our practice undergo imaging at these three time points. We suspect that there has been and will be fewer women with saline implants requiring revision due to the increased popularity of silicone implants. We only acquired the 3D imaging system in December 2013, and since then have been imaging all of our patients requiring deflation. In addition, we did not have a non-deflation control group. We are continuing to accrue patients into our study and plan to reanalyze our data in the future to see if our results are statistically significant. Furthermore, the deflation volumes are approximate, as the values are measured by looking at the values in the suction canister. One further consideration for future studies is to remove this aspirated fluid and measure this more accurately in a beaker or weigh the saline.
Another weakness is that there is a degree of variability in the measurements depending on where the breast landmarks are placed by hand. However, we attempted to minimize this variability by taking several measurements and reporting the average. In addition, volume measurements were in general more variable as the grade of ptosis increased or when the patient was heavier. This is due to the fact that the IMF marker cannot be accurately placed if covered by breast tissue, if the abdominal contour is obese, or if there are chest wall irregularities. For this reason, we chose to calculate volumes with the Analysis program (as opposed to the Sculptor program, which is the program used to generate breast measurements and select implants in augmentation patients). Unlike the Sculptor measurement of volume, the Analysis program extrapolates chest and abdominal wall irregularities and subtracts its volume from the breast volume. This extrapolation may have a degree of inaccuracy as well, since it is a computer-simulated volume. Due to these shortcomings, we use 3D imaging as an adjunct, and not as an independent tool, for preoperative planning. The deflation volume is also very helpful in choosing implant size. For example, a patient presents with macromastia and ptosis, and desires replacement with a smaller implant with mastopexy. The deflation volume is 350 mL, and 3D imaging shows an increase of 50 mL from immediately post-deflation (Time 2) to 3 weeks post-deflation (Time 3). If after 3 weeks she is satisfied with her breast volume, the deflated implant is removed and a mastopexy only is performed. If after 3 weeks she wants to be a little larger, but not as large as before, we would pick a smaller implant that was less than the prior 350 mL implant volume (for example, 250 mL) and perform a removal and replacement with a smaller implant as well as the mastopexy.
The patients' ages ranged from 17 to 68 years in the entire cohort, and from 27 to 61 years in the 3D imaging subset. We stratified patient age by the percentage volume change between Time 3 and Time 2, and did not find a consistent relationship. Preoperative mammography images were not available in all patients, and the density of the breast is not routinely dictated in the consultation or operative note. For these reasons, we are unable to draw conclusions on the relationship of age and breast density to the degree of elastic breast recoil.
Lastly, one theoretical confounding variable to volume measurements could be the presence of a seroma after the deflation process. In all of our revisions, we have not noted any significant seroma formation in our patients at the time of definitive correction and shell removal. In two patients with heavily calcified capsules, reaccumulation of milky fluid after deflation occurred within a week. Re-deflation revealed milky fluid (laboratory studies revealed it was a lactocele and not a lymphocele). These patients went on to revisional surgery without adverse sequelae.
We have not performed these volume measurements at any other longer or shorter time intervals to compare volume changes over time. However, we feel confident that the algorithm that we currently use with 4 weeks of deflation seems to allow the changes to occur without subjecting the patient to a more prolonged period without definitive correction. We have considered performing serial imaging between Time 2 and Time 3 in order to pinpoint the exact time at which the elastic recoil becomes stable, but this would place further inconvenience on the patient. The timing of our imaging, first at the initial consult (Time 1), then immediately after deflation (Time 2), and then 3 weeks after deflation (Time 3), coincides with necessary clinic visits. We felt that additional visits for imaging would have potentially made patients more self-conscious about their deflated breasts than necessary. The 2D and 3D images taken immediately after deflation (Time 2) occur at the same office visit during which the decision to deflate occurs, and the images taken 3 weeks later (Time 3) occur during the office visit for final preoperative planning, thus obviating the need for an additional clinic visit just for pictures. In the future, we plan to shorten the interval between Times 2 and 3 to determine the minimal period of deflation needed to achieve a stable gland.
We feel that the period of deflation has the added advantage of allowing the patient "to get back in touch with her own body": that is, to be able to see how much breast tissue she actually has and whether or not her volume has changed enough to allow her to get rid of the implants completely. Many patients are surprised to find that they don 0 t actually need the implants any longer to fulfill their aesthetic goals. Preoperative saline deflation is easy to perform and has considerable value for both the patient and the reoperating plastic surgeon.
CONCLUSIONS
Breast volume appears to increase after saline implant deflation in the 3 week interval prior to reoperation. A possible explanation for this is shortening of the suspensory ligaments and recovery of parenchyma that have previously been stretched by the implant, with resultant re-expansion of the gland. This "elastic breast recoil" phenomenon is important to note prior to secondary breast surgery. We find that a 4-week period is optimal for the gland to normalize prior to definitive correction. Ideal candidates include patients requiring secondary mastopexy without implants, implant downsizing in the same pocket, and secondary augmentation mastopexy. Preoperative saline deflation and 3D analysis are useful for preoperative planning in reoperative breast surgery.
